Log In
BCIQ
Print this Print this
 

EGFRvIII CAR

  Manage Alerts
Collapse Summary General Information
Company Kite Pharma Inc.
DescriptionChimeric antigen receptor (CAR) targeting epidermal growth factor variant III (EGFRvIII) antigen
Molecular Target Epidermal growth factor variant III (EGFRvIII)
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Non-stem cell
Latest Stage of DevelopmentPhase I/II
Standard IndicationBrain cancer
Indication DetailsTreat glioblastoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today